Cancer Drugs Could be Hitting Wrong Targets
Current cancer drugs may be hitting the wrong protein targets, a study has found, giving a possible explanation for the low success rates of those drugs during their early stages. The study, recently published in Science Translational Medicine journal and...
5 years agoCancer Drugs Could be Hitting Wrong Targets
Current cancer drugs may be hitting the wrong protein targets, a study has found, giving a possible explanation for the low success rates of those drugs during their early stages. The study, recently published in Science Translational Medicine journal and...
5 years ago
Google – The New Pharmaceutical Regulator?
Last Friday, Google stated in a press release that it would no longer be accepting advertisements for “speculative and experimental medical treatments”, including most stem cell or gene therapies, after observing unscrupulous companies taking advantage of patients through offers of...
5 years agoGoogle – The New Pharmaceutical Regulator?
Last Friday, Google stated in a press release that it would no longer be accepting advertisements for “speculative and experimental medical treatments”, including most stem cell or gene therapies, after observing unscrupulous companies taking advantage of patients through offers of...
5 years ago